
2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients
S. Kahan, S. Spanik, M. Wagnerova, T. Skacel, B. Planko, E. Fitzthum, E. Lindner, V. Soldatenkova, C.C. Zielinski, T. BrodowiczVolume:
5
Année:
2007
Langue:
english
DOI:
10.1016/s1359-6349(07)70857-1
Fichier:
PDF, 78 KB
english, 2007